Related Experiment Video
Updated: May 5, 2026

08:42
Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
2.6K
Progressive Increase of Regulatory T Cells and Decrease of CD8+ T Cells and CD8+ T Cells/Regulatory T Cells Ratio
1Department of Pathology, Dongguk University College of Medicine, Gyeongju, Korea.
Korean Journal of Pathology
|November 21, 2013
Summary
Regulatory T cells (Tregs) increase while CD8+ T cells decrease during colorectal cancer (CRC) development, impacting the immune microenvironment. This CD8+ T cell/Tregs ratio shift is linked to COX-2 expression and disease progression.
Area of Science:
- Immunology
- Oncology
- Gastroenterology
Background:
- Colorectal cancer (CRC) development involves complex immune system alterations.
- Understanding the roles of CD8+ T cells and regulatory T cells (Tregs) is crucial in CRC pathogenesis.
- Cyclooxygenase-2 (COX-2) expression is implicated in tumor microenvironment modulation.
Purpose of the Study:
- To analyze the distribution of CD8+ T cells and Tregs in colorectal lesions.
- To determine the CD8+ T cell/Tregs ratio across different stages of CRC development.
- To investigate the correlation between Tregs and COX-2 expression in CRC.
Main Methods:
- Immunohistochemical staining was performed for CD8, forkhead box P3 (Tregs marker), E-cadherin, and COX-2.
- Analysis included invasive CRC, intramucosal CRC, tubular adenomas (high and low grade), and non-neoplastic tissues.
- Quantification of immune cell infiltration and protein expression was conducted.
Main Results:
- A progressive increase in Tregs and a decrease in CD8+ T cells were observed during CRC development.
- The CD8+ T cell/Tregs ratio significantly decreased, particularly in high-grade lesions and invasive CRC.
- COX-2 expression showed a positive association with Treg infiltration; T cell ratios varied by tumor compartment.
Conclusions:
- The observed alterations in CD8+ T cell and Treg distribution create an immune environment conducive to CRC development and progression.
- The CD8+ T cell/Tregs ratio is a potential biomarker for CRC progression.
- Targeting immune cell interactions and COX-2 may offer therapeutic strategies for CRC.
Related Concept Videos
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Inflammatory Bowel Disease III: Crohn's Disease
69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69

